Advertisement

Topics

Polyganics Company Profile

03:29 EDT 23rd October 2018 | BioPortfolio

Polyganics is a medical technology company with multiple versatile polymer platforms. The Company develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate tissue repair and regeneration.


News Articles [6 Associated News Articles listed on BioPortfolio]

Baxter unit enters distribution deal with Polyganics

Baxter International subsidiary Synovis Micro Companies Alliance has agreed to exclusively distribute Polyganics' Neurocap ne -More- 

Synovis MCA to distribute Polyganics’ nerve capping device in US

Polyganics’ Neurocap nerve capping device protects the peripheral nerve end, separates it from the environment to avoid further damage and pain. Introduced in 2016, Neurocap is a treatment opti...

Polyganics Strengthens Global Distribution Network with Appointment of Synovis MCA as US-wide Distributor of NEUROCAP®

Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices, today announced that it has signed an agreeme...

Polyganics BV Product Pipeline Analysis, 2018 Update [Report Updated: 22052018] Prices from USD $750

SummaryPolyganics BV Polyganics is a medical technology company that develops, manufactures and commercializes bioresorbable medical devices which facilitate tissue repair and regeneration. The compan...

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

Groningen, The Netherlands, 22 October 2018 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced that it has ...

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

Groningen, The Netherlands, October 22, 2018 / B3C newswire / -- Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma

This post-market surveillance study is conducted to provide post market surveillance information regarding long-term performance and ease of use of the Polyganics nerve capping device (NEU...

Surgical Treatment of Symptomatic Neuroma

This study is conducted to clinically assess safety and performance of the Polyganics nerve capping device for the treatment of symptomatic neuroma. There is sufficient clinical experience...

Companies [1 Associated Companies listed on BioPortfolio]

Polyganics

Polyganics is a medical technology company with multiple versatile polymer platforms. The Company develops, manufactures and commercializes innovative bioresorbable medical device...

More Information about "Polyganics" on BioPortfolio

We have published hundreds of Polyganics news stories on BioPortfolio along with dozens of Polyganics Clinical Trials and PubMed Articles about Polyganics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Polyganics Companies in our database. You can also find out about relevant Polyganics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record